REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 1 filers reported holding REPROS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $525,000 | +46.2% | 794,913 | -29.2% | 0.00% | – |
| Q3 2017 | $359,000 | -18.4% | 1,122,013 | +17.4% | 0.00% | -100.0% |
| Q2 2017 | $440,000 | -49.6% | 956,013 | +31.5% | 0.00% | 0.0% |
| Q1 2017 | $873,000 | -7.7% | 727,113 | +1.5% | 0.00% | 0.0% |
| Q4 2016 | $946,000 | -32.1% | 716,413 | +7.4% | 0.00% | -50.0% |
| Q3 2016 | $1,394,000 | +54.2% | 667,113 | +18.8% | 0.00% | 0.0% |
| Q2 2016 | $904,000 | +425.6% | 561,713 | +216.1% | 0.00% | – |
| Q1 2016 | $172,000 | +319.5% | 177,713 | +424.0% | 0.00% | – |
| Q4 2015 | $41,000 | -87.7% | 33,913 | -24.5% | 0.00% | -100.0% |
| Q3 2015 | $334,000 | -76.9% | 44,900 | -77.8% | 0.00% | -66.7% |
| Q2 2015 | $1,445,000 | – | 202,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
| RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
| SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
| CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
| Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
| Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
| Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |